Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Clin Exp Med ; 23(6): 2287-2299, 2023 Oct.
Article in English | MEDLINE | ID: mdl-36939968

ABSTRACT

This study aimed to uncover the current major topics regarding COVID-19 vaccine, and systematically evaluate the development trends for future research. The top 100 most cited original articles on COVID-19 vaccine from January 2020 to October 2022 were identified from Web of Science Core Collection database. CiteSpace (v6.1.R3) was adopted for bibliometric analysis with statistical and visual analysis. The number of citations ranged from 206 to 5881, with a median of 349.5. The USA (n = 56), England (n = 33), and China (n = 16) ranked the top three countries/regions in terms of the number of publications. Harvard Medical School (centrality = 0.71), Boston Children's Hospital (centrality = 0.67), and Public Health England (centrality = 0.57) were the top three institutions leading the way on COVID-19 vaccine research. The New England of medicine journal dominated with 22 articles in the 32 high-quality journals. The three most frequent keywords were immunization (centrality = 0.25), influenza vaccination (centrality = 0.21), and coronavirus (centrality = 0.18). Cluster analysis of keywords showed that the top four categories were protection efficacy, vaccine hesitancy, spike protein, and second vaccine dose (Q value = 0.535, S value = 0.879). Cluster analysis of cited references showed that top eight largest categories were Cov-2 variant, clinical trial, large integrated health system, COV-2 rhesus macaque, mRNA vaccine, vaccination intent, phase II study, and Cov-2 omicron variant (Q value = 0.672, S value = 0.794). The research on COVID-19 vaccine is currently the hottest topic in academic community. At present, COVID-19 vaccines researches have focused on vaccine efficacy, vaccine hesitancy, and the efficacy of current vaccines on omicron variants. However, how to increase vaccine uptake, focus on mutations in the spike protein, evaluate of the efficacy of booster vaccine, and how effective new vaccines under pre- and clinical development against omicron will be spotlight in the future.


Subject(s)
COVID-19 Vaccines , COVID-19 , Child , Animals , Humans , Macaca mulatta , Spike Glycoprotein, Coronavirus , COVID-19/prevention & control , SARS-CoV-2 , Bibliometrics
2.
Br J Nutr ; 129(10): 1812-1819, 2023 05 28.
Article in English | MEDLINE | ID: mdl-35872569

ABSTRACT

Immunoprophylaxis has not completely eliminated hepatitis B virus (HBV) infection due to hyporesponsiveness to hepatitis B vaccine (HepB). We explored the impact of folic acid supplementation (FAS) in pregnant women with positive hepatitis B surface antigen (HBsAg) on their infant hepatitis B surface antibody (anti-HBs) and the mediation effect of infant interleukin-4 (IL-4). We recruited HBsAg-positive mothers and their neonates at baseline. Maternal FAS was obtained via a questionnaire, and neonatal anti-HBs and IL-4 were detected. Follow-up was performed at 11-13 months of age of infants, when anti-HBs and IL-4 were measured. We applied univariate and multivariate analyses. A mediation effect model was performed to explore the mediating role of IL-4. A total of 399 mother-neonate pairs were enrolled and 195 mother-infant pairs were eligible for this analysis. The infant anti-HBs geometric mean concentrations in the maternal FAS group were significnatly higher than those in the no-FAS group (383·8 mIU/ml, 95 % CI: 294·2 mIU/ml to 500·7 mIU/ml v. 217·0 mIU/ml, 95 % CI: 147·0 mIU/ml to 320·4 mIU/ml, z = -3·2, P = 0·001). Infants born to women who took folic acid (FA) within the first trimester were more likely to have high anti-HBs titres (adjusted ß-value = 194·1, P = 0·003). The fold change in IL-4 from neonates to infants partially mediated the beneficial influence of maternal FAS on infant anti-HBs (24·7 % mediation effect) after adjusting for confounding factors. FAS during the first trimester to HBsAg-positive mothers could facilitate higher anti-HBs levels in infants aged 11-13 months partly by upregulating IL-4 in infants.


Subject(s)
Hepatitis B Surface Antigens , Hepatitis B , Female , Humans , Infant , Infant, Newborn , Pregnancy , Dietary Supplements , Hepatitis B/prevention & control , Hepatitis B/drug therapy , Hepatitis B Antibodies , Hepatitis B Vaccines/therapeutic use , Interleukin-4 , Pregnant Women , Folic Acid/pharmacology
3.
Environ Health ; 21(1): 48, 2022 05 06.
Article in English | MEDLINE | ID: mdl-35513839

ABSTRACT

BACKGROUND: Polycyclic aromatic hydrocarbons (PAHs) and its DNA adducts has been suggested to increase the risk of preterm birth (PB). Yet, few studies have been conducted to investigate this association, and the role of dietary nutrients intakes including vitamins, folate, and carotene during pre- and post-conception on this association has not been studied. METHODS: Building upon a birth cohort in Taiyuan China, we conducted a nested case control study including 83 PB and 82 term births. Benzo[a]pyrene (BaP)-DNA adducts were measured by an improved LC-MC/MC analytic method. Dietary nutrient intakes were estimated from food frequency questionnaire using the Chinese Standard Tables of Food Consumption. Multivariable logistic regression model was used to examine the associations. RESULTS: Increased risk of PB was observed as per interquartile increase in maternal BaP-DNA adduct level (OR = 1.27, 95%CI 0.95-1.67). Compared to low level (below mean) of maternal adducts, high level (above mean) of adducts was associated with the risk of PB (OR = 2.05, 95%CI 1.05-4.01). After stratified by dietary nutrients intakes, high adducts levels were associated with approximately 2-fourfold times increases in risk of PB among women with low vitamin A, C, E, folate, and carotene intakes during pre- and/or post-conception. Stronger stratified associations were consistently seen during preconception. Similar patterns were observed after additional adjustment for supplementation. CONCLUSIONS: Our study supports the hypothesis that high level of maternal PAHs exposure was significantly associated with increased risk of PB, and provides the first evidence that dietary vitamins, carotene, and folate intake levels may modify this association during different pregnancy windows. Our findings are relevant to identify recommendation for environment management and prenatal nutrition regarding pregnant women and newborns. Further investigation in other populations is warranted.


Subject(s)
Polycyclic Aromatic Hydrocarbons , Premature Birth , Benzo(a)pyrene/analysis , Birth Cohort , Carotenoids , Case-Control Studies , China/epidemiology , DNA Adducts , Female , Folic Acid , Humans , Infant, Newborn , Male , Pregnancy , Premature Birth/chemically induced , Premature Birth/epidemiology , Vitamin A , Vitamins
4.
Article in English | MEDLINE | ID: mdl-35032891

ABSTRACT

In traditional Chinese medicine (TCM), components with identical nuclei often share structural similarity, indicating the possibility of similar second-level mass spectrometry (MS/MS) fragments. High-resolution product-ion filter (HRPIF) technique can be utilized to identify metabolites, with similar fragments, in vivo. In principle, this technique applies to TCM; however, its application has been restricted due to the limitations of traditional MS/MS data acquisition. Therefore, a novel analysis strategy, based on data-dependent acquisition (DDA) and data-independent acquisition (DIA) datasets, has been developed for the determination of template product ions and efficient non-targeted identification of TCM-related components in vivo by HRPIF and background subtraction (BS). This DDA-DIA combination strategy, taking Rhei Radix et Rhizoma as a test case, identified 71 anthraquinone prototype components in vitro (36 of which were discovered for the first time), and 45 related components in vivo, confirming glucuronidation and sulfation as the main reactions. The developed strategy could rapidly identify TCM-related components in vivo with high sensitivity, indicating the immense importance of this novel HRPIF data mining technology in TCM analysis.


Subject(s)
Data Mining/methods , Drugs, Chinese Herbal/metabolism , Rheum/chemistry , Rhizome/chemistry , Administration, Oral , Animals , Anthraquinones/administration & dosage , Anthraquinones/blood , Anthraquinones/chemistry , Anthraquinones/metabolism , Drugs, Chinese Herbal/administration & dosage , Drugs, Chinese Herbal/chemistry , Male , Molecular Structure , Plasma/chemistry , Rats , Rats, Sprague-Dawley , Tandem Mass Spectrometry
5.
Acta Pharm Sin B ; 11(1): 222-236, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33072499

ABSTRACT

Lianhuaqingwen (LHQW) capsule, a herb medicine product, has been clinically proved to be effective in coronavirus disease 2019 (COVID-19) pneumonia treatment. However, human exposure to LHQW components and their pharmacological effects remain largely unknown. Hence, this study aimed to determine human exposure to LHQW components and their anti-COVID-19 pharmacological activities. Analysis of LHQW component profiles in human plasma and urine after repeated therapeutic dosing was conducted using a combination of HRMS and an untargeted data-mining approach, leading to detection of 132 LHQW prototype and metabolite components, which were absorbed via the gastrointestinal tract and formed via biotransformation in human, respectively. Together with data from screening by comprehensive 2D angiotensin-converting enzyme 2 (ACE2) biochromatography, 8 components in LHQW that were exposed to human and had potential ACE2 targeting ability were identified for further pharmacodynamic evaluation. Results show that rhein, forsythoside A, forsythoside I, neochlorogenic acid and its isomers exhibited high inhibitory effect on ACE2. For the first time, this study provides chemical and biochemical evidence for exploring molecular mechanisms of therapeutic effects of LHQW capsule for the treatment of COVID-19 patients based on the components exposed to human. It also demonstrates the utility of the human exposure-based approach to identify pharmaceutically active components in Chinese herb medicines.

6.
Int J Syst Evol Microbiol ; 70(6): 3665-3672, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32416735

ABSTRACT

Two novel Gram-stain-positive, irregular rod-shaped bacterial strains, dk3136T and dk3543, were isolated from the faeces of Tibetan gazelle (Procapra picticaudata) in the Qinghai-Tibet Plateau of PR China. The cells were aerobic, oxidase-negative and catalase-positive. Colonies were yellowish, circular without any observable aerial mycelium after culturing at 28 ℃ for 3 days on brain-heart infusion (BHI) agar with 5 % sheep blood. The cells grew optimally at 28 °C, pH 7.5 and with 1 % (w/v) NaCl on BHI agar supplemented with 5 % sheep blood. Phylogenetic analysis of the 16S rRNA gene sequences revealed that their nearest phylogenetic relative was Nocardioides solisilvae Ka25T (97.9 % similarity). The results of 16S rRNA gene sequence and phylogenetic/phylogenomic analyses illustrated that N. solisilvae Ka25T, Nocardioides gilvus XZ17T, Nocardioides houyundeii 78T and Nocardioides daphniae D287T were their nearest phylogenetic neighbours. The DNA G+C contents of strains dk3136T and dk3543 were 70.3 mol% and 70.4 mol%, respectively. Their genomes exhibit lower than threshold (95-96 %) average nucleotide identity to known species of the genus Nocardioides. ll-2,6-diaminopimelic acid was the diagnostic diamino acid and MK-8(H4) was the predominant respiratory quinone. The major polar lipids were diphosphatidylglycerol and phosphatidylglycerol. The two strains had C18 : 1 ω9c, iso-C16 : 0 and C17 : 1 ω8c as the major fatty acids, and rhamnose and galactose as the main whole-cell sugars. On the basis of the results of our genotypic, phenotypic and biochemical analyses, we conclude that strains dk3136T and dk3543 represent a novel species in genus Nocardioides, for which the name Nocardioides jishulii sp. nov. is proposed. The type strain is dk3136T (=CGMCC 4.7570T=JCM 33496T=KCTC 49314T).


Subject(s)
Actinobacteria/classification , Antelopes/microbiology , Feces/microbiology , Phylogeny , Actinobacteria/isolation & purification , Animals , Bacterial Typing Techniques , Base Composition , DNA, Bacterial/genetics , Fatty Acids/chemistry , Peptidoglycan/chemistry , Phospholipids/chemistry , Pigmentation , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA , Tibet , Vitamin K 2/analogs & derivatives , Vitamin K 2/chemistry
7.
Pharmacol Res ; 159: 104935, 2020 09.
Article in English | MEDLINE | ID: mdl-32464328

ABSTRACT

Xiaokewan is a typical Traditional Chinese medicine (TCM) for diabetes and contains various natural chemicals, such as lignans, flavonoids, saponins, polysaccharides, and western medicine glibenclamide. In the current study, a highly efficient system for screening hypoglycemic efficacy constituents of Xiaokewan has been developed with the integration of intelligent data acquisition, data mining, network pharmacology, and computer assisted target fishing. With the combination of background exclusion data dependent acquisition (BE-DDA) and non-targeted precise-and-thorough background-subtraction (PATBS) techniques, a novel workflow has been established for the non-targeted recognition and identification of TCM constituents in vivo, and has been applied to the exposure study of Xiaokewan in rat. In this case, an interesting correlation among drug, target, and disease can be established, by combining the screening or characterization results with the strategy of network pharmacology and multiple computer assisted techniques. Consequently, five main constituents (puerarin, daidzein, formononetin, deoxyschizandrin and glibenclamide) exposed in vivo have been selected as effective hypoglycemic components. Meanwhile, the network pharmacology experimental results showed that these five constituents could act on various drug targets, such as PI3K, PTP1B, MAPK, AKT, TNF, and NF-κB. These five constituents might be involved in the regulation of ß-cell function or exhibit inflammation inhibition ability to relieve the pathophysiological process of disease from multiple links. Furthermore, the pharmacological effects of these five constituents have been verified by diabetic zebrafish model. The zebrafish model results showed that the TCM monomer mixture without glibenclamide exhibited similar hypoglycemic activity with Xiaokewan. Although the monomer mixture with glibenclamide showed better activity than Xiaokewan only, the deoxyschizandrin (TCM constituent of Xiaokewan) exhibited best hypoglycemic performance. In summary, the above results indicated that the application of both intelligent recognition technology in mass spectrometry dataset and computerized network pharmacology might provide a pioneering approach for investigating the substance basis of TCM and searching lead compounds from natural sources.


Subject(s)
Artificial Intelligence , Blood Glucose/drug effects , Diabetes Mellitus/drug therapy , Drugs, Chinese Herbal/pharmacology , Hypoglycemic Agents/pharmacology , Systems Biology , Animals , Animals, Genetically Modified , Biomarkers/blood , Blood Glucose/metabolism , Chromatography, High Pressure Liquid , Data Mining , Diabetes Mellitus/blood , Diabetes Mellitus/genetics , Disease Models, Animal , Drugs, Chinese Herbal/therapeutic use , Gene Regulatory Networks , Male , Protein Interaction Maps , Rats, Wistar , Spectrometry, Mass, Electrospray Ionization , Tandem Mass Spectrometry , Workflow , Zebrafish/embryology , Zebrafish/genetics
8.
J Stroke Cerebrovasc Dis ; 27(7): e148-e149, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29555398

ABSTRACT

Thalamic infarcts, accounting for approximately 14% of lacunar infarcts, exhibit varied clinical manifestations due to complex anatomy of nuclei and varying blood supply. Pure and combined types of thalamic infarctions have been summarized in some paper, but information of cerebral angiography was not mentioned. Here we report a rare case of combined tuberothalamic and paramedian artery occlusion presenting with ipsilateral ptosis and contralateral ataxic hemiparesis.


Subject(s)
Blepharoptosis/diagnosis , Brain Infarction/diagnosis , Paresis/diagnosis , Aged, 80 and over , Blepharoptosis/drug therapy , Blepharoptosis/etiology , Brain Infarction/drug therapy , Brain Infarction/etiology , Cerebral Arteries/diagnostic imaging , Diagnosis, Differential , Functional Laterality , Humans , Male , Mesencephalon/diagnostic imaging , Paresis/drug therapy , Paresis/etiology , Thalamus/diagnostic imaging
9.
Curr Microbiol ; 69(5): 740-4, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25002358

ABSTRACT

Endophytic fungi are ubiquitous in the plant kingdom and they produce a variety of secondary metabolites to protect plant communities and to show some potential for human use. However, secondary metabolites produced by endophytic fungi in the medicinal plant Curcuma wenyujin are sparsely explored and characterized. The aim of this study was to characterize the secondary metabolites of an active endophytic fungus. M7226, the mutant counterpart of endophytic fungus EZG0807 previously isolated from the root of C. wenyujin, was as a target strain. After fermentation, the secondary metabolites were purified using a series of purification methods including thin layer chromatography, column chromatography with silica, ODS-C18, Sephadex LH-20, and macroporous resin, and were analyzed using multiple pieces of data (UV, IR, MS, and NMR). Five compounds were isolated and identified as curcumin, cinnamic acid, 1,4-dihydroxyanthraquinone, gibberellic acid, and kaempferol. Interestingly, curcumin, one of the main active ingredients of C. wenyujin, was isolated as a secondary metabolite from a fungal endophyte for the first time.


Subject(s)
Biological Products/analysis , Curcuma/microbiology , Endophytes/chemistry , Fungi, Unclassified/chemistry , Chromatography , Endophytes/isolation & purification , Fungi, Unclassified/isolation & purification , Magnetic Resonance Spectroscopy , Mass Spectrometry , Spectrophotometry, Infrared , Spectrophotometry, Ultraviolet
10.
J Neurosci ; 34(5): 1903-15, 2014 Jan 29.
Article in English | MEDLINE | ID: mdl-24478369

ABSTRACT

Ischemic stroke is a debilitating clinical disorder that affects millions of people, yet lacks effective neuroprotective treatments. Fish oil is known to exert beneficial effects against cerebral ischemia. However, the underlying protective mechanisms are not fully understood. The present study tests the hypothesis that omega-3 polyunsaturated fatty acids (n-3 PUFAs) attenuate ischemic neuronal injury by activating nuclear factor E2-related factor 2 (Nrf2) and upregulating heme oxygenase-1 (HO-1) in both in vitro and in vivo models. We observed that pretreatment of rat primary neurons with docosahexaenoic acid (DHA) significantly reduced neuronal death following oxygen-glucose deprivation. This protection was associated with increased Nrf2 activation and HO-1 upregulation. Inhibition of HO-1 activity with tin protoporphyrin IX attenuated the protective effects of DHA. Further studies showed that 4-hydroxy-2E-hexenal (4-HHE), an end-product of peroxidation of n-3 PUFAs, was a more potent Nrf2 inducer than 4-hydroxy-2E-nonenal derived from n-6 PUFAs. In an in vivo setting, transgenic mice overexpressing fatty acid metabolism-1, an enzyme that converts n-6 PUFAs to n-3 PUFAs, were remarkably resistant to focal cerebral ischemia compared with their wild-type littermates. Regular mice fed with a fish oil-enhanced diet also demonstrated significant resistance to ischemia compared with mice fed with a regular diet. As expected, the protection was associated with HO-1 upregulation, Nrf2 activation, and 4-HHE generation. Together, our data demonstrate that n-3 PUFAs are highly effective in protecting the brain, and that the protective mechanisms involve Nrf2 activation and HO-1 upregulation by 4-HHE. Further investigation of n-3 PUFA neuroprotective mechanisms may accelerate the development of stroke therapies.


Subject(s)
Brain Injuries/prevention & control , Brain Ischemia/metabolism , Fatty Acids, Omega-3/therapeutic use , Heme Oxygenase-1/metabolism , NF-E2-Related Factor 2/metabolism , Up-Regulation/drug effects , Aldehydes/pharmacology , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Brain Injuries/etiology , Brain Ischemia/complications , Brain Ischemia/physiopathology , Cadherins/genetics , Cell Death/drug effects , Cells, Cultured , Cerebral Cortex/cytology , Disease Models, Animal , Docosahexaenoic Acids/pharmacology , Dose-Response Relationship, Drug , Embryo, Mammalian , Fatty Acids, Omega-3/pharmacology , Female , Glucose/deficiency , Hypoxia/prevention & control , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microtubule-Associated Proteins/metabolism , Neurons/drug effects , Rats , Time Factors
11.
Exp Neurol ; 218(2): 213-20, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19427306

ABSTRACT

Recent discoveries show that caspase-independent cell death pathways are a pervasive mechanism in neurodegenerative diseases, and apoptosis-inducing factor (AIF) is an important effector of this mode of neuronal death. There are currently two known mechanisms underlying AIF release following excitotoxic stress, PARP-1 and calpain. To test whether there is an interaction between PARP-1 and calpain in triggering AIF release, we used the NMDA toxicity model in rat primary cortical neurons. Exposure to NMDA resulted in AIF truncation and nuclear translocation, and shRNA-mediated knockdown of AIF resulted in neuroprotection. Both calpain and PARP-1 are involved with AIF processing as AIF truncation, nuclear translocation and neuronal death were attenuated by calpain inhibition using adeno-associated virus-mediated overexpression of the endogenous calpain inhibitor, calpastatin, or treatment with the PARP-1 inhibitor 3-ABA. Activation of PARP-1 is necessary for calpain activation as PARP-1 inhibition blocked mitochondrial calpain activation. Finally, NMDA toxicity induces mitochondrial Ca(2+) dysregulation in a PARP-1 dependent manner. Thus, PARP-1 and mitochondrial calpain activation are linked via PARP-1-induced alterations in mitochondrial Ca(2+) homeostasis. Collectively, these findings link the two seemingly independent mechanisms triggering AIF-induced neuronal death.


Subject(s)
Apoptosis Inducing Factor/biosynthesis , Calcium/metabolism , Calpain/metabolism , Mitochondria/metabolism , Neurons/metabolism , Poly(ADP-ribose) Polymerases/metabolism , Signal Transduction/drug effects , Analysis of Variance , Animals , Apoptosis/drug effects , Blotting, Western , Cells, Cultured , Cerebral Cortex/cytology , DNA, Complementary , Excitatory Amino Acid Agonists/pharmacology , Genetic Vectors , Green Fluorescent Proteins/metabolism , Mitochondria/drug effects , N-Methylaspartate/pharmacology , Neurons/drug effects , Poly (ADP-Ribose) Polymerase-1 , RNA, Small Interfering , Rats , Rats, Sprague-Dawley , Transfection
12.
Zhongguo Zhong Yao Za Zhi ; 28(9): 851-3, 2003 Sep.
Article in Chinese | MEDLINE | ID: mdl-15015381

ABSTRACT

OBJECTIVE: To study the relationship between the protection of Ginsenoside(GS) for spinal cells and nitric oxide (NO). METHOD: Spinal cells were cultured in vitro, the model of peripheral nerve was established by scarifying the cells, and NO was measured by Griess method. RESULT: NO in injury group was high than that in noninjury group and NO in group cultured by GS was less than that in group cultured by common medium. CONCLUSION: NO increases when peripheral nerve is injuried, and the protective effect of GS on spinal cells may be through inhibiting NO release.


Subject(s)
Ginsenosides/pharmacology , Neuroprotective Agents/pharmacology , Nitric Oxide/metabolism , Spinal Cord/metabolism , Animals , Cells, Cultured , Fetus , Ginsenosides/isolation & purification , Motor Neurons/cytology , Motor Neurons/drug effects , Motor Neurons/metabolism , Neurons, Afferent/cytology , Neurons, Afferent/drug effects , Neurons, Afferent/metabolism , Panax/chemistry , Plants, Medicinal/chemistry , Rats , Rats, Sprague-Dawley , Spinal Cord/cytology
SELECTION OF CITATIONS
SEARCH DETAIL